Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2014 (2014), Article ID 152087, 11 pages
http://dx.doi.org/10.1155/2014/152087
Review Article

Radiofrequency Ablation for Early-Stage Nonsmall Cell Lung Cancer

Department of Radiology, Okayama University Medical School, 2-5-1 Shikatacho, Okayama 700-8558, Japan

Received 23 March 2014; Accepted 20 May 2014; Published 3 June 2014

Academic Editor: Masanori Inoue

Copyright © 2014 Takao Hiraki et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. E. Vrdoljak, K. Miše, D. Sapunar, A. Rozga, and M. Marušić, “Survival analysis of untreated patients with non-small-cell lung cancer,” Chest, vol. 106, no. 6, pp. 1797–1800, 1994. View at Google Scholar · View at Scopus
  2. R. C. McGarry, G. Song, P. des Rosiers, and R. Timmerman, “Observation-only management of early stage, medically inoperable lung cancer,” Chest, vol. 121, no. 4, pp. 1155–1158, 2002. View at Publisher · View at Google Scholar · View at Scopus
  3. R. J. Ginsberg and L. V. Rubinstein, “Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer,” The Annals of Thoracic Surgery, vol. 60, no. 3, pp. 615–623, 1995. View at Publisher · View at Google Scholar · View at Scopus
  4. P. B. Bach, L. D. Cramer, J. L. Warren, and C. B. Begg, “Racial differences in the treatment of early-stage lung cancer,” The New England Journal of Medicine, vol. 341, no. 16, pp. 1198–1205, 1999. View at Publisher · View at Google Scholar · View at Scopus
  5. X. Qiao, O. Tullgren, I. Lax, F. Sirzen, and R. Lewensohn, “The role of radiotherapy in treatment of stage I non-small cell lung cancer,” Lung Cancer, vol. 41, no. 1, pp. 1–11, 2003. View at Publisher · View at Google Scholar · View at Scopus
  6. D. E. Dupuy, R. J. Zagoria, W. Akerley, W. W. Mayo-Smith, P. V. Kavanagh, and H. Safran, “Percutaneous radiofrequency ablation of malignancies in the lung,” The American Journal of Roentgenology, vol. 174, no. 1, pp. 57–59, 2000. View at Google Scholar · View at Scopus
  7. M. Ahmed, Z. Liu, K. S. Afzal et al., “Radiofrequency ablation: effect of surrounding tissue composition on coagulation necrosis in a canine tumor model,” Radiology, vol. 230, no. 3, pp. 761–767, 2004. View at Publisher · View at Google Scholar · View at Scopus
  8. C. L. Nguyen, W. J. Scott, N. A. Young, T. R. Rader, L. R. Giles, and M. Goldberg, “Radiofrequency ablation of primary lung cancer: results from an ablate and resect pilot study,” Chest, vol. 128, no. 5, pp. 3507–3511, 2005. View at Publisher · View at Google Scholar · View at Scopus
  9. M. C. Ambrogi, G. Fontanini, R. Cioni, P. Faviana, O. Fanucchi, and A. Mussi, “Biologic effects of radiofrequency thermal ablation on non-small cell lung cancer: results of a pilot study,” The Journal of Thoracic and Cardiovascular Surgery, vol. 131, no. 5, pp. 1002–1006, 2006. View at Publisher · View at Google Scholar · View at Scopus
  10. J. M. Lee, G. Y. Jin, S. N. Goldberg et al., “Percutaneous radiofrequency ablation for inoperable non-small cell lung cancer and metastases: preliminary report,” Radiology, vol. 230, no. 1, pp. 125–134, 2004. View at Publisher · View at Google Scholar · View at Scopus
  11. H. C. Fernando, A. de Hoyos, R. J. Landreneau et al., “Radiofrequency ablation for the treatment of non-small cell lung cancer in marginal surgical candidates,” The Journal of Thoracic and Cardiovascular Surgery, vol. 129, no. 3, pp. 639–644, 2005. View at Publisher · View at Google Scholar · View at Scopus
  12. A. Pennathur, J. D. Luketich, G. Abbas et al., “Radiofrequency ablation for the treatment of stage I non-small cell lung cancer in high-risk patients,” The Journal of Thoracic and Cardiovascular Surgery, vol. 134, no. 4, pp. 857–864, 2007. View at Publisher · View at Google Scholar · View at Scopus
  13. C. J. Simon, D. E. Dupuy, T. A. DiPetrillo et al., “Pulmonary radiofrequency ablation: long-term safety and efficacy in 153 patients,” Radiology, vol. 243, no. 1, pp. 268–275, 2007. View at Publisher · View at Google Scholar · View at Scopus
  14. T. Hiraki, H. Gobara, T. Iishi et al., “Percutaneous radiofrequency ablation for clinical stage I non-small cell lung cancer: results in 20 nonsurgical candidates,” The Journal of Thoracic and Cardiovascular Surgery, vol. 134, no. 5, pp. 1306–1312, 2007. View at Publisher · View at Google Scholar · View at Scopus
  15. R. Lencioni, L. Crocetti, R. Cioni et al., “Response to radiofrequency ablation of pulmonary tumours: a prospective, intention-to-treat, multicentre clinical trial (the RAPTURE study),” The Lancet Oncology, vol. 9, no. 7, pp. 621–628, 2008. View at Publisher · View at Google Scholar · View at Scopus
  16. M. Lanuti, A. Sharma, S. R. Digumarthy et al., “Radiofrequency ablation for treatment of medically inoperable stage I non-small cell lung cancer,” The Journal of Thoracic and Cardiovascular Surgery, vol. 137, no. 1, pp. 160–166, 2009. View at Publisher · View at Google Scholar · View at Scopus
  17. A. Zemlyak, W. H. Moore, and T. V. Bilfinger, “Comparison of survival after sublobar resections and ablative therapies for stage I non-small cell lung cancer,” Journal of the American College of Surgeons, vol. 211, no. 1, pp. 68–72, 2010. View at Publisher · View at Google Scholar · View at Scopus
  18. T. Hiraki, H. Gobara, H. Mimura, Y. Matsui, S. Toyooka, and S. Kanazawa, “Percutaneous radiofrequency ablation of clinical stage I non-small cell lung cancer,” The Journal of Thoracic and Cardiovascular Surgery, vol. 142, no. 1, pp. 24–30, 2011. View at Publisher · View at Google Scholar · View at Scopus
  19. L. Huang, Y. Han, J. Zhao et al., “Is radiofrequency thermal ablation a safe and effective procedure in the treatment of pulmonary malignancies?” European Journal of Cardio-Thoracic Surgery, vol. 39, no. 3, pp. 348–351, 2011. View at Publisher · View at Google Scholar · View at Scopus
  20. M. C. Ambrogi, O. Fanucchi, R. Cioni et al., “Long-term results of radiofrequency ablation treatment of stage I non-small cell lung cancer: a prospective intention-to-treat study,” Journal of Thoracic Oncology, vol. 6, no. 12, pp. 2044–2051, 2011. View at Publisher · View at Google Scholar · View at Scopus
  21. T. G. Simon, M. D. Beland, J. T. Machan, T. Dipetrillo, and D. E. Dupuy, “Charlson comorbidity index predicts patient outcome, in cases of inoperable non-small cell lung cancer treated with radiofrequency ablation,” European Journal of Radiology, vol. 81, no. 12, pp. 4167–4172, 2012. View at Publisher · View at Google Scholar · View at Scopus
  22. M. Lanuti, A. Sharma, H. Willers, S. R. Digumarthy, D. J. Mathisen, and J. O. Shepard, “Radiofrequency ablation for stage I non-small cell lung cancer: management of locoregional recurrence,” The Annals of Thoracic Surgery, vol. 93, no. 3, pp. 921–927, 2012. View at Publisher · View at Google Scholar · View at Scopus
  23. H. Lee, G. Y. Jin, Y. M. Han et al., “Comparison of survival rate in primary non-small-cell lung cancer among elderly patients treated with radiofrequency ablation, surgery, or chemotherapy,” CardioVascular and Interventional Radiology, vol. 35, no. 2, pp. 343–350, 2012. View at Publisher · View at Google Scholar · View at Scopus
  24. H. Onishi, K. Kuriyama, T. Komiyama et al., “Clinical outcomes of stereotactic radiotherapy for stage I non-small cell lung cancer using a novel irradiation technique: patient self-controlled breath-hold and beam switching using a combination of linear accelerator and CT scanner,” Lung Cancer, vol. 45, no. 1, pp. 45–55, 2004. View at Publisher · View at Google Scholar · View at Scopus
  25. Y. Nagata, K. Takayama, Y. Matsuo et al., “Clinical outcomes of a phase I/II study of 48 Gy of stereotactic body radiotherapy in 4 fractions for primary lung cancer using a stereotactic body frame,” International Journal of Radiation Oncology Biology Physics, vol. 63, no. 5, pp. 1427–1431, 2005. View at Publisher · View at Google Scholar · View at Scopus
  26. F. B. Zimmermann, H. Geinitz, S. Schill et al., “Stereotactic hypofractionated radiation therapy for stage I non-small cell lung cancer,” Lung Cancer, vol. 48, no. 1, pp. 107–114, 2005. View at Publisher · View at Google Scholar · View at Scopus
  27. J. Nyman, K. A. Johansson, and U. Hultén, “Stereotactic hypofractionated radiotherapy for stage I non-small cell lung cancer—mature results for medically inoperable patients,” Lung Cancer, vol. 51, no. 1, pp. 97–103, 2006. View at Publisher · View at Google Scholar · View at Scopus
  28. R. Timmerman, R. McGarry, C. Yiannoutsos et al., “Excessive toxicity when treating central tumors in a phase II study of stereotactic body radiation therapy for medically inoperable early-stage lung cancer,” Journal of Clinical Oncology, vol. 24, no. 30, pp. 4833–4839, 2006. View at Publisher · View at Google Scholar · View at Scopus
  29. H. Onishi, H. Shirato, Y. Nagata et al., “Hypofractionated stereotactic radiotherapy (HypoFXSRT) for stage I non-small cell lung cancer: updated results of 257 patients in a Japanese multi-institutional study,” Journal of Thoracic Oncology, vol. 2, no. 7, supplement 3, pp. S94–S100, 2007. View at Publisher · View at Google Scholar · View at Scopus
  30. P. Baumann, J. Nyman, M. Hoyer et al., “Outcome in a prospective phase II trial of medically inoperable stage I non-small-cell lung cancer patients treated with stereotactic body radiotherapy,” Journal of Clinical Oncology, vol. 27, no. 20, pp. 3290–3296, 2009. View at Publisher · View at Google Scholar · View at Scopus
  31. A. J. Fakiris, R. C. McGarry, C. T. Yiannoutsos et al., “Stereotactic body radiation therapy for early-stage non-small-cell lung carcinoma: four-year results of a prospective phase II study,” International Journal of Radiation Oncology Biology Physics, vol. 75, no. 3, pp. 677–682, 2009. View at Publisher · View at Google Scholar · View at Scopus
  32. U. Ricardi, A. R. Filippi, A. Guarneri et al., “Stereotactic body radiation therapy for early stage non-small cell lung cancer: results of a prospective trial,” Lung Cancer, vol. 68, no. 1, pp. 72–77, 2010. View at Publisher · View at Google Scholar · View at Scopus
  33. R. Timmerman, R. Paulus, J. Galvin et al., “Stereotactic body radiation therapy for inoperable early stage lung cancer,” The Journal of the American Medical Association, vol. 303, no. 11, pp. 1070–1076, 2010. View at Publisher · View at Google Scholar · View at Scopus
  34. H. Onishi, H. Shirato, Y. Nagata et al., “Stereotactic body radiotherapy (SBRT) for operable stage I non-small-cell lung cancer: can SBRT be comparable to surgery?” International Journal of Radiation Oncology Biology Physics, vol. 81, no. 5, pp. 1352–1358, 2011. View at Publisher · View at Google Scholar · View at Scopus
  35. F. J. Lagerwaard, N. E. Verstegen, C. J. A. Haasbeek et al., “Outcomes of stereotactic ablative radiotherapy in patients with potentially operable stage I non-small cell lung cancer,” International Journal of Radiation Oncology Biology Physics, vol. 83, no. 1, pp. 348–353, 2012. View at Publisher · View at Google Scholar · View at Scopus
  36. Y. Shibamoto, C. Hashizume, F. Baba et al., “Stereotactic body radiotherapy using a radiobiology-based regimen for stage I nonsmall cell lung cancer: a multicenter study,” Cancer, vol. 118, no. 8, pp. 2078–2084, 2012. View at Publisher · View at Google Scholar · View at Scopus
  37. T. D. Crabtree, V. Puri, C. Robinson et al., “Analysis of first recurrence and survival in patients with stage I non-small cell lung cancer treated with surgical resection or stereotactic radiation therapy,” The Journal of Thoracic and Cardiovascular Surgery, vol. 147, no. 4, pp. 1183–1192, 2014. View at Google Scholar
  38. T. Crabtree, V. Puri, R. Timmerman et al., “Treatment of stage I lung cancer in high-risk and inoperable patients: comparison of prospective clinical trials using stereotactic body radiotherapy (RTOG 0236), sublobar resection (ACOSOG Z4032), and radiofrequency ablation (ACOSOG Z4033),” The Journal of Thoracic and Cardiovascular Surgery, vol. 145, no. 3, pp. 692–699, 2013. View at Publisher · View at Google Scholar · View at Scopus
  39. S. R. Kim, H. J. Han, S. J. Park et al., “Comparison between surgery and radiofrequency ablation for stage I non-small cell lung cancer,” European Journal of Radiology, vol. 81, no. 2, pp. 395–399, 2012. View at Publisher · View at Google Scholar · View at Scopus
  40. S. W. Kwan, K. E. Mortell, A. D. Talenfeld, and M. C. Brunner, “Thermal ablation matches sublobar resection outcomes in older patients with early-stage non-small cell lung cancer,” Journal of Vascular and Interventional Radiology, vol. 25, no. 1, pp. 1–9, 2014. View at Publisher · View at Google Scholar
  41. E. S. Alexander, J. T. Machan, T. Ng, L. D. Breen, T. A. Dipetrillo, and D. E. Dupuy, “Cost and effectiveness of radiofrequency ablation versus limited surgical resection for stage I non-small-cell lung cancer in elderly patients: is less more?” Journal of Vascular and Interventional Radiology, vol. 24, no. 4, pp. 476–482, 2013. View at Publisher · View at Google Scholar · View at Scopus
  42. D. J. Sher, J. O. Wee, and R. S. Punglia, “Cost-effectiveness analysis of stereotactic body radiotherapy and radiofrequency ablation for medically inoperable, early-stage non-small cell lung cancer,” International Journal of Radiation Oncology Biology Physics, vol. 81, no. 5, pp. e767–e774, 2011. View at Publisher · View at Google Scholar · View at Scopus
  43. J. A. Howington, M. G. Blum, A. C. Chang, A. A. Balekian, and S. C. Murthy, “Treatment of stage I and II non-small cell lung cancer: diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines,” Chest, vol. 143, no. 5, supplement, pp. e278S–e313S, 2013. View at Publisher · View at Google Scholar · View at Scopus
  44. J. Donington, M. Ferguson, P. Mazzone et al., “American College of Chest Physicians and Society of Thoracic Surgeons consensus statement for evaluation and management for high-risk patients with stage I non-small cell lung cancer,” Chest, vol. 142, no. 6, pp. 1620–1635, 2012. View at Publisher · View at Google Scholar · View at Scopus
  45. D. E. Dupuy, T. DiPetrillo, S. Gandhi et al., “Radiofrequency ablation followed by conventional radiotherapy for medically inoperable stage I non-small cell lung cancer,” Chest, vol. 129, no. 3, pp. 738–745, 2006. View at Publisher · View at Google Scholar · View at Scopus
  46. H. Kodama, K. Yamakado, H. Takaki et al., “Lung radiofrequency ablation for the treatment of unresectable recurrent non-small-cell lung cancer after surgical intervention,” CardioVascular and Interventional Radiology, vol. 35, no. 3, pp. 563–569, 2012. View at Publisher · View at Google Scholar · View at Scopus
  47. H. Schoellnast, A. Deodhar, M. Hsu et al., “Recurrent non-small cell lung cancer: evaluation of CT-guided radiofrequency ablation as salvage therapy,” Acta Radiologica, vol. 53, no. 8, pp. 893–899, 2012. View at Publisher · View at Google Scholar · View at Scopus
  48. R. S. Santos, A. Gupta, M. I. Ebright et al., “Electromagnetic navigation to aid radiofrequency ablation and biopsy of lung tumors,” The Annals of Thoracic Surgery, vol. 89, no. 1, pp. 265–268, 2010. View at Publisher · View at Google Scholar · View at Scopus
  49. F. Banovac, P. Cheng, E. Campos-Nanez et al., “Radiofrequency ablation of lung tumors in swine assisted by a navigation device with preprocedural volumetric planning,” Journal of Vascular and Interventional Radiology, vol. 21, no. 1, pp. 122–129, 2010. View at Publisher · View at Google Scholar · View at Scopus
  50. G. D. Dodd III, M. S. Frank, M. Aribandi, S. Chopra, and K. N. Chintapalli, “Radiofrequency thermal ablation: computer analysis of the size of the thermal injury created by overlapping ablations,” American Journal of Roentgenology, vol. 177, no. 4, pp. 777–782, 2001. View at Google Scholar · View at Scopus
  51. K. Tsushima, T. Kolzumi, T. Tanabe et al., “Bronchoscopy-guided radiofrequency ablation as a potential novel therapeutic tool,” European Respiratory Journal, vol. 29, no. 6, pp. 1193–1200, 2007. View at Publisher · View at Google Scholar · View at Scopus
  52. T. Tanabe, T. Koizumi, K. Tsushima et al., “Comparative study of three different catheters for CT imaging-bronchoscopy-guided radiofrequency ablation as a potential and novel interventional therapy for lung cancer,” Chest, vol. 137, no. 4, pp. 890–897, 2010. View at Publisher · View at Google Scholar · View at Scopus
  53. A. S. Wright, L. A. Sampson, T. F. Warner, D. M. Mahvi, and F. T. Lee Jr., “Radiofrequency versus microwave ablation in a hepatic porcine model,” Radiology, vol. 236, no. 1, pp. 132–139, 2005. View at Publisher · View at Google Scholar · View at Scopus
  54. Y. Yamauchi, Y. Izumi, K. Hashimoto et al., “Percutaneous cryoablation for the treatment of medically inoperable Stage I non-small cell lung cancer,” PLoS ONE, vol. 7, no. 3, Article ID e33223, 2012. View at Publisher · View at Google Scholar · View at Scopus
  55. A. Deodhar, S. Monette, G. W. Single Jr. et al., “Percutaneous irreversible electroporation lung ablation: preliminary results in a porcine model,” CardioVascular and Interventional Radiology, vol. 34, no. 6, pp. 1278–1287, 2011. View at Publisher · View at Google Scholar · View at Scopus
  56. E. W. Lee, C. Chen, V. E. Prieto, S. M. Dry, C. T. Loh, and S. T. Kee, “Advanced hepatic ablation technique for creating complete cell death: irreversible electroporation,” Radiology, vol. 255, no. 2, pp. 426–433, 2010. View at Publisher · View at Google Scholar · View at Scopus